Literature DB >> 12449179

Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome.

I Chakravorty1, R M Cayton, A Szczepura.   

Abstract

Formulating a rational health policy necessitates the ability to compare between different healthcare interventions and disease scenarios. Continuous positive airway pressure (CPAP) therapy with a conservative lifestyle strategy in sleep apnoea/hypopnoea syndrome (SAHS) was evaluated using health utility and quality-adjusted life years (QALYs) as outcome measures. A total 71 SAHS (apnoea/hypopnoea index > or = 15 h(-1)) patients completed a randomised, parallel group study over 3 months using utilities derived by the standard gamble approach (Usg) and European quality of life questionnaire (Euroqol) (Ueq). The severely impaired health status at baseline improved by 23% (Usg 0.32 to 0.55) adding 8 QALYs in the CPAP group, compared to a 4% improvement with 4.7 QALYs added in the lifestyle group (Usg 0.31 to 0.35). The Ueq showed a marginal change with CPAP (0.73 to 0.77) but did not demonstrate any improvement with lifestyle intervention. The health status impairment in sleep apnoea/hypopnoea syndrome patients is markedly improved by continuous positive airway pressure compared to a modest improvement with conservative lifestyle strategies using the standard gamble utility, which may be incorporated in effectiveness and economic analyses. The European quality of life questionnaire did not reflect a similar degree of impact and is probably not useful in this population.

Entities:  

Mesh:

Year:  2002        PMID: 12449179     DOI: 10.1183/09031936.00.00014401

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  19 in total

1.  Visual analogical well-being scale for sleep apnea patients: validity and responsiveness : a test for clinical practice.

Authors:  Juan F Masa; Antonio Jiménez; Joaquín Durán; Carmen Carmona; Carmen Monasterio; Mercedes Mayos; Joaquín Terán; Ferrán Barbé; Manuela Rubio; Inmaculada Failde; Manuel Mota; José M Montserrat
Journal:  Sleep Breath       Date:  2010-08-05       Impact factor: 2.816

Review 2.  New developments in the use of positive airway pressure for obstructive sleep apnea.

Authors:  Lucas M Donovan; Schafer Boeder; Atul Malhotra; Sanjay R Patel
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

3.  Medicare long-term CPAP coverage policy: a cost-utility analysis.

Authors:  Martha E Billings; Vishesh K Kapur
Journal:  J Clin Sleep Med       Date:  2013-10-15       Impact factor: 4.062

4.  Long-Term Cost-Effectiveness of Upper Airway Stimulation for the Treatment of Obstructive Sleep Apnea: A Model-Based Projection Based on the STAR Trial.

Authors:  Jan B Pietzsch; Shan Liu; Abigail M Garner; Eric J Kezirian; Patrick J Strollo
Journal:  Sleep       Date:  2015-05-01       Impact factor: 5.849

Review 5.  Non-surgical treatment of obstructive sleep apnea syndrome.

Authors:  Xu Tingting; You Danming; Chen Xin
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-24       Impact factor: 2.503

6.  An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea.

Authors:  Jan B Pietzsch; Abigail Garner; Lauren E Cipriano; John H Linehan
Journal:  Sleep       Date:  2011-06-01       Impact factor: 5.849

7.  Development of a Sleep Apnea-Specific Health State Utility Algorithm.

Authors:  Jonathan R Skirko; Kathryn T James; Louis P Garrison; Edward M Weaver
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-03-01       Impact factor: 6.223

Review 8.  When continuous positive airway pressure (CPAP) fails.

Authors:  Jagdeep S Virk; Bhik Kotecha
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 9.  Effect on quality of life of continuous positive airway pressure in patients with obstructive sleep apnea syndrome: a meta-analysis.

Authors:  Jiyong Jing; Tiancha Huang; Wei Cui; Huahao Shen
Journal:  Lung       Date:  2008-03-14       Impact factor: 2.584

10.  Cost-effectiveness of continuous positive airway pressure therapy in patients with obstructive sleep apnea-hypopnea in British Columbia.

Authors:  M C Y Tan; N T Ayas; A Mulgrew; L Cortes; J M FitzGerald; J A Fleetham; M Schulzer; C F Ryan; R Ghaeli; P Cooper; C A Marra
Journal:  Can Respir J       Date:  2008-04       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.